Atlas Trials

An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC

Clinical trial NCT07482891 · RECRUITING

Trial details

NCT number
NCT07482891
Sponsor
Shanghai 6th People's Hospital
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chemotherapy-induced Nausea and Vomiting
Start date
2026-03-10
Primary completion
2026-10-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.